Charles Schwab’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,430
| Closed | -$12.9K | – | 3572 |
|
|
2023
Q3 | $12.9K | Hold |
12,430
| – | – | ﹤0.01% | 3545 |
|
|
2023
Q2 | $17.5K | Hold |
12,430
| – | – | ﹤0.01% | 3573 |
|
|
2023
Q1 | $19.8K | Hold |
12,430
| – | – | ﹤0.01% | 3509 |
|
|
2022
Q4 | $18.1K | Hold |
12,430
| – | – | ﹤0.01% | 3510 |
|
|
2022
Q3 | $54K | Buy |
+12,430
| New | +$54K | ﹤0.01% | 3316 |
|
|
2022
Q2 | – | Sell |
-79,118
| Closed | -$377K | – | 3667 |
|
|
2022
Q1 | $377K | Sell |
79,118
-6,942
| -8% | -$33.1K | ﹤0.01% | 3159 |
|
|
2021
Q4 | $315K | Hold |
86,060
| – | – | ﹤0.01% | 3275 |
|
|
2021
Q3 | $691K | Buy |
86,060
+2,268
| +3% | +$18.2K | ﹤0.01% | 3027 |
|
|
2021
Q2 | $951K | Buy |
+83,792
| New | +$951K | ﹤0.01% | 2948 |
|
|
2015
Q3 | – | Sell |
-219
| Closed | -$139K | – | 3100 |
|
|
2015
Q2 | $139K | Sell |
219
-328
| -60% | -$208K | ﹤0.01% | 3026 |
|
|
2015
Q1 | $282K | Buy |
547
+201
| +58% | +$104K | ﹤0.01% | 2858 |
|
|
2014
Q4 | $186K | Sell |
346
-188
| -35% | -$101K | ﹤0.01% | 2991 |
|
|
2014
Q3 | $801K | Buy |
534
+11
| +2% | +$16.5K | ﹤0.01% | 2403 |
|
|
2014
Q2 | $716K | Buy |
523
+88
| +20% | +$120K | ﹤0.01% | 2489 |
|
|
2014
Q1 | $605K | Buy |
435
+87
| +25% | +$121K | ﹤0.01% | 2515 |
|
|
2013
Q4 | $347K | Buy |
348
+95
| +38% | +$94.7K | ﹤0.01% | 2729 |
|
|
2013
Q3 | $267K | Sell |
253
-24
| -9% | -$25.3K | ﹤0.01% | 2803 |
|
|
2013
Q2 | $321K | Buy |
+277
| New | +$321K | ﹤0.01% | 2704 |
|